Patient Guide: Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 63 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04867837
Status: 🟢 Enrolling Now
Condition: Hemorrhage
Phase: PHASE3

Where You Can Participate

This study is available at 63 locations across the country.

Top locations include:
  • • Torrance, California
  • • Gainesville, Florida
  • • West Palm Beach, Florida
  • • And 60 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor - Join Clinical Trial NCTNCT04867837

How to Join This Clinical Trial - NCTNCT04867837

Learn how to participate in this PHASE3 trial studying an investigational therapy for Hemorrhage. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hemorrhage. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hemorrhage
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04867837 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 63 locations. Find a study site near you:

Clinical Research Site

Torrance, California 90509 - United States

Status: TERMINATED

Clinical Research Site

Gainesville, Florida 32610 - United States

Status: RECRUITING

Clinical Research Site

West Palm Beach, Florida 33407 - United States

Status: RECRUITING

Clinical Research Site

Boston, Massachusetts 02215 - United States

Status: TERMINATED

Clinical Research Site

Minneapolis, Minnesota 55415 - United States

Status: TERMINATED

Clinical Research Site

Jackson, Mississippi 39216 - United States

Status: TERMINATED

Clinical Research Site

Oklahoma City, Oklahoma 73104 - United States

Status: TERMINATED

Clinical Research Site

Portland, Oregon 97239 - United States

Status: TERMINATED

Clinical Research Site

Austin, Texas 78712 - United States

Status: TERMINATED

Clinical Research Site

Austin, Texas 78712 - United States

Status: TERMINATED

And 53 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Hemorrhage:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships